CASQ2 rs397507555: Understanding CPVT2 Genetic Associations
The rs397507555 variant is a rare genetic change located within the CASQ2 gene. It is primarily studied for its association with catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2), a rare inherited condition that affects the heart's electrical rhythm.
What each genotype means
Typical CASQ2 genotype
This is the most common genotype observed in the general population. It represents the typical sequence for the CASQ2 gene, which provides instructions for the calsequestrin 2 protein involved in cardiac calcium regulation.
This genotype is found in the vast majority of the global population.
Carrier of rare variant
This genotype indicates the presence of a rare deletion variant in the CASQ2 gene. Because this variant is extremely rare and associated with catecholaminergic polymorphic ventricular tachycardia (CPVT2) in some clinical contexts, individuals with this result should discuss the findings with a cardiologist or genetic counselor to understand its clinical relevance in their specific health history.
This genotype is extremely rare, occurring in less than 0.001% of global populations.
What is the rs397507555 Variant?
The rs397507555 variant is a specific change in the DNA sequence of the CASQ2 gene. In genomics, an rsID (reference SNP cluster ID) like rs397507555 acts as a unique identifier for a specific location in the human genome. This variant is categorized as a rare genetic change, meaning it is not commonly found in the general population. When researchers identify such variants, they look for patterns to see if the change in the DNA code correlates with specific health outcomes. Because this variant is located within the CASQ2 gene, scientists focus on how it might alter the instructions for building the calsequestrin-2 protein. Understanding the location and nature of this variant is the first step in determining whether it has a functional impact on how heart muscle cells manage their internal chemistry.
The Role of the CASQ2 Gene
The CASQ2 gene provides the blueprint for a protein called calsequestrin-2. This protein is essential for the proper function of cardiac myocytes, which are the muscle cells that make up the heart. Within these cells, calsequestrin-2 acts as a storage tank for calcium ions inside a specialized structure called the sarcoplasmic reticulum. During a heartbeat, calcium must be released and reabsorbed in a highly controlled manner to trigger muscle contraction and relaxation. When the CASQ2 gene is functioning normally, it ensures that calcium is stored securely and released only when needed. If the gene contains a pathogenic mutation, the resulting protein may be missing or dysfunctional, which can lead to calcium leaking out of the storage area. This leakage can disrupt the electrical stability of the heart, potentially leading to irregular heartbeats, especially during periods of physical or emotional stress.
Research and Clinical Associations
Research has linked certain variants in the CASQ2 gene to catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2). CPVT2 is a rare, inherited cardiac arrhythmia characterized by life-threatening heart rhythm disturbances that are often triggered by exercise or intense emotion. The evidence for the pathogenicity of specific CASQ2 variants is generally considered moderate to strong in the context of clinical genetics, as these mutations are known to disrupt calcium homeostasis. However, it is important to note that not all variants in a gene have the same effect. While some mutations cause a complete loss of protein function, others may have milder or unknown consequences. Current research continues to investigate how different CASQ2 variants contribute to the spectrum of CPVT symptoms, ranging from asymptomatic carriers to those who experience syncope or more severe cardiac events.
Population Frequency and Interpretation
The rs397507555 variant is extremely rare, with a frequency reported at less than 0.001% in global populations according to large-scale databases like gnomAD. Because it is so uncommon, it is not a variant that the average person would typically encounter in routine genetic screening. When a variant is this rare, it is often identified in the context of clinical testing for individuals who have already presented with symptoms of a cardiac condition. It is crucial to understand that the presence of a rare variant does not automatically mean an individual will develop a disease. Genetic testing results should always be interpreted by a qualified medical professional, such as a genetic counselor or a cardiologist, who can place the finding in the context of an individual's personal and family medical history.
What You Can and Cannot Do With This Information
Information about genetic variants like rs397507555 is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you have received a report mentioning this variant, it is essential to discuss the findings with a healthcare provider. They can help determine if the variant is relevant to your health or if it is a benign finding. You cannot use this information to make decisions about medication or lifestyle changes without professional guidance. If you are concerned about your heart health or a family history of arrhythmias, consult a cardiologist who specializes in inherited cardiac conditions. They can provide appropriate screening, such as an ECG or stress test, to assess your heart's function. Never change your medication or treatment plan based on genetic data without consulting your doctor or pharmacist.
How common is this variant?
The rs397507555 variant is extremely rare in global populations, with a frequency of less than 0.001% in gnomAD datasets.
Frequently asked questions
What is CPVT2?
CPVT2 stands for catecholaminergic polymorphic ventricular tachycardia type 2. It is a rare, inherited heart condition that causes dangerous heart rhythm irregularities, usually triggered by exercise or emotional stress.
Is rs397507555 a dangerous mutation?
The rs397507555 variant is associated with CPVT2, a serious condition. However, the clinical significance of any specific variant depends on many factors, and you should consult a cardiologist to understand what it means for your specific health.
Should I get tested for CASQ2 variants?
Genetic testing for CASQ2 is typically recommended only for individuals with a personal or family history of unexplained cardiac events or diagnosed arrhythmias. You should discuss the necessity of such testing with a medical professional.
Can I fix a CASQ2 mutation?
Currently, there is no way to 'fix' a genetic mutation. Treatment for conditions like CPVT2 focuses on managing symptoms and preventing arrhythmias through medications like beta-blockers or other medical interventions prescribed by a doctor.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs397507555?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29